Investigating the protective effects of aged garlic extract on cyclosporin-induced nephrotoxicity in rats

Orawan Wongmekiat1, Kamthorn Thamprasert

  • 1Department of Physiology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand. wongmekiat_o@yahoo.co.uk

Insights

Aged garlic extract (AGE) shows protective effects against cyclosporin A (CsA)-induced kidney damage. AGE treatment significantly improved kidney function and reduced harmful histological changes in rats, suggesting it may help prevent CsA nephrotoxicity.

Area of Science:

  • Nephrology
  • Pharmacology
  • Toxicology

Background:

  • Cyclosporin A (CsA) is known to cause kidney damage (nephrotoxicity), particularly in organ transplant recipients and those with autoimmune diseases.
  • Oxidative stress and lipid peroxidation are key factors in the development of CsA-induced renal injury.
  • Aged garlic extract (AGE) possesses antioxidant and free radical scavenging properties.

Purpose of the Study:

  • To investigate the potential protective effects of Aged Garlic Extract (AGE) against Cyclosporin A (CsA)-induced nephrotoxicity.
  • To evaluate the impact of AGE on biochemical markers and renal histopathology in a rat model of CsA nephrotoxicity.

Main Methods:

  • Male Wistar rats were administered CsA (50 mg/kg/day) orally for 10 days.
  • Rats received varying doses of AGE (0.25, 0.5, 1, and 2 g/kg/day) starting 3 days prior to CsA treatment.
  • Kidney function was assessed by measuring blood urea nitrogen, serum creatinine, and creatinine clearance. Renal histopathology was also examined.

Main Results:

  • CsA significantly increased blood urea nitrogen and serum creatinine, while decreasing creatinine clearance, indicating severe nephrotoxicity.
  • AGE treatment at doses of 0.5, 1, and 2 g/kg significantly ameliorated these biochemical changes.
  • Histopathological examination revealed that AGE (0.5-2 g/kg) markedly improved CsA-induced tubular necrosis and vacuolations.

Conclusions:

  • Aged Garlic Extract (AGE) demonstrates a significant protective effect against Cyclosporin A (CsA)-induced nephrotoxicity in rats.
  • AGE treatment improved kidney function and reduced structural damage caused by CsA.
  • These findings suggest that AGE could be a beneficial therapeutic agent for mitigating CsA-induced renal injury.